Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Radding

Jeffrey Radding has joined Epitome Biosystems as vice president for research and development, the company announced this week.
Prior to joining Epitome, Radding headed the Platform Biology Group at Eli Lilly. The group evaluated and implemented cell signaling approaches for drug discovery across multiple therapeutic areas.
Radding obtained his PhD in chemistry from Indiana University.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.